Cargando…

Optogenetically controlled human functional motor endplate for testing botulinum neurotoxins

BACKGROUND: The lack of physiologically relevant and predictive cell-based assays is one of the major obstacles for testing and developing botulinum neurotoxins (BoNTs) therapeutics. Human-induced pluripotent stem cells (hiPSCs)-derivatives now offer the opportunity to improve the relevance of cellu...

Descripción completa

Detalles Bibliográficos
Autores principales: de Lamotte, Juliette Duchesne, Polentes, Jérôme, Roussange, Florine, Lesueur, Léa, Feurgard, Pauline, Perrier, Anselme, Nicoleau, Camille, Martinat, Cécile
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8647380/
https://www.ncbi.nlm.nih.gov/pubmed/34865655
http://dx.doi.org/10.1186/s13287-021-02665-3
_version_ 1784610594905653248
author de Lamotte, Juliette Duchesne
Polentes, Jérôme
Roussange, Florine
Lesueur, Léa
Feurgard, Pauline
Perrier, Anselme
Nicoleau, Camille
Martinat, Cécile
author_facet de Lamotte, Juliette Duchesne
Polentes, Jérôme
Roussange, Florine
Lesueur, Léa
Feurgard, Pauline
Perrier, Anselme
Nicoleau, Camille
Martinat, Cécile
author_sort de Lamotte, Juliette Duchesne
collection PubMed
description BACKGROUND: The lack of physiologically relevant and predictive cell-based assays is one of the major obstacles for testing and developing botulinum neurotoxins (BoNTs) therapeutics. Human-induced pluripotent stem cells (hiPSCs)-derivatives now offer the opportunity to improve the relevance of cellular models and thus the translational value of preclinical data. METHODS: We investigated the potential of hiPSC-derived motor neurons (hMNs) optical stimulation combined with calcium imaging in cocultured muscle cells activity to investigate BoNT-sensitivity of an in vitro model of human muscle-nerve system. RESULTS: Functional muscle-nerve coculture system was developed using hMNs and human immortalized skeletal muscle cells. Our results demonstrated that hMNs can innervate myotubes and induce contractions and calcium transient in muscle cells, generating an in vitro human motor endplate showing dose-dependent sensitivity to BoNTs intoxication. The implementation of optogenetics combined with live calcium imaging allows to monitor the impact of BoNTs intoxication on synaptic transmission in human motor endplate model. CONCLUSIONS: Altogether, our findings demonstrate the promise of optogenetically hiPSC-derived controlled muscle-nerve system for pharmaceutical BoNTs testing and development. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13287-021-02665-3.
format Online
Article
Text
id pubmed-8647380
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-86473802021-12-07 Optogenetically controlled human functional motor endplate for testing botulinum neurotoxins de Lamotte, Juliette Duchesne Polentes, Jérôme Roussange, Florine Lesueur, Léa Feurgard, Pauline Perrier, Anselme Nicoleau, Camille Martinat, Cécile Stem Cell Res Ther Research BACKGROUND: The lack of physiologically relevant and predictive cell-based assays is one of the major obstacles for testing and developing botulinum neurotoxins (BoNTs) therapeutics. Human-induced pluripotent stem cells (hiPSCs)-derivatives now offer the opportunity to improve the relevance of cellular models and thus the translational value of preclinical data. METHODS: We investigated the potential of hiPSC-derived motor neurons (hMNs) optical stimulation combined with calcium imaging in cocultured muscle cells activity to investigate BoNT-sensitivity of an in vitro model of human muscle-nerve system. RESULTS: Functional muscle-nerve coculture system was developed using hMNs and human immortalized skeletal muscle cells. Our results demonstrated that hMNs can innervate myotubes and induce contractions and calcium transient in muscle cells, generating an in vitro human motor endplate showing dose-dependent sensitivity to BoNTs intoxication. The implementation of optogenetics combined with live calcium imaging allows to monitor the impact of BoNTs intoxication on synaptic transmission in human motor endplate model. CONCLUSIONS: Altogether, our findings demonstrate the promise of optogenetically hiPSC-derived controlled muscle-nerve system for pharmaceutical BoNTs testing and development. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13287-021-02665-3. BioMed Central 2021-12-05 /pmc/articles/PMC8647380/ /pubmed/34865655 http://dx.doi.org/10.1186/s13287-021-02665-3 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
de Lamotte, Juliette Duchesne
Polentes, Jérôme
Roussange, Florine
Lesueur, Léa
Feurgard, Pauline
Perrier, Anselme
Nicoleau, Camille
Martinat, Cécile
Optogenetically controlled human functional motor endplate for testing botulinum neurotoxins
title Optogenetically controlled human functional motor endplate for testing botulinum neurotoxins
title_full Optogenetically controlled human functional motor endplate for testing botulinum neurotoxins
title_fullStr Optogenetically controlled human functional motor endplate for testing botulinum neurotoxins
title_full_unstemmed Optogenetically controlled human functional motor endplate for testing botulinum neurotoxins
title_short Optogenetically controlled human functional motor endplate for testing botulinum neurotoxins
title_sort optogenetically controlled human functional motor endplate for testing botulinum neurotoxins
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8647380/
https://www.ncbi.nlm.nih.gov/pubmed/34865655
http://dx.doi.org/10.1186/s13287-021-02665-3
work_keys_str_mv AT delamottejulietteduchesne optogeneticallycontrolledhumanfunctionalmotorendplatefortestingbotulinumneurotoxins
AT polentesjerome optogeneticallycontrolledhumanfunctionalmotorendplatefortestingbotulinumneurotoxins
AT roussangeflorine optogeneticallycontrolledhumanfunctionalmotorendplatefortestingbotulinumneurotoxins
AT lesueurlea optogeneticallycontrolledhumanfunctionalmotorendplatefortestingbotulinumneurotoxins
AT feurgardpauline optogeneticallycontrolledhumanfunctionalmotorendplatefortestingbotulinumneurotoxins
AT perrieranselme optogeneticallycontrolledhumanfunctionalmotorendplatefortestingbotulinumneurotoxins
AT nicoleaucamille optogeneticallycontrolledhumanfunctionalmotorendplatefortestingbotulinumneurotoxins
AT martinatcecile optogeneticallycontrolledhumanfunctionalmotorendplatefortestingbotulinumneurotoxins